Breast Cancer Clinical Trial

The Impact of Functional Medicine On Wound Healing From Delayed Autologous Breast Reconstruction

Summary

This study will examine if a functional medicine approach, delivered as an adjunct to standard of care, is feasible, safe, clinically beneficial and cost-effective for patients undergoing autologous breast reconstruction.

View Full Description

Full Description

Autologous microsurgical breast reconstruction is associated with a protracted recovery and a significant amount of opioid utilization. Many institutions have "Enhanced Recovery After Surgery (ERAS)" protocols that utilize multi-modality therapy to decrease opioid use, length of stay, hospital costs and expedite recovery. However, nutrition-based interventions used perioperatively are not currently part of ERAS protocols for surgical sub-specialties, including breast surgery despite ample literature that nutrition (with or without supplements) can improve surgical wound healing and other outcomes.

The functional medicine model of care expands upon the conventional medicine model of care by providing a unique operating system that works to reverse illness, promote health and optimize function. A foundation of functional medicine is the use of food as medicine to prevent, treat and reverse chronic disease. Dietary supplements are used as an adjunct to nutrition-based interventions. Dietitians support patients with implementing food plans, and health coaches support patients through lifestyle and behavioral changes focused on sleep, exercise and movement and stress reduction.

This study will examine the feasibility of implementing a functional medicine-based intervention focused on nutrition and lifestyle, and the ability of the intervention to improve wound healing and decrease various post-operative complications in patients undergoing autologous breast reconstruction.

All participants will be asked to attend study visits, complete questionnaires and have their blood drawn. Participants randomized to standard of care plus functional medicine will be asked to also follow a specific food plan, take specific dietary supplements, exercise and engage in stress reduction techniques for 3 months prior to and after surgery. The study duration is 6 months.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Undergoing uni- or bilateral delayed abdominally-based breast reconstruction at the Cleveland Clinic.
Women of childbearing potential must use adequate birth control measures (e.g., abstinence, oral contraceptives, intrauterine device, barrier method with spermicide, implantable or injectable contraceptives or surgical sterilization) for the duration of the study.
Capable of providing written informed consent prior to any protocol-specified procedures.
Willing to adhere to the study visit schedule and other protocol requirements.

Exclusion Criteria:

BMI > 37
Prior radiation therapy to breast
Women who are pregnant, nursing, or planning pregnancy during the trial.
Have a serious concomitant illness that could interfere with the subject's participation in the trial (allergy preventing supplement usage)
Undergoing chemotherapy during proposed nutritional intervention (3 months before or after surgery).
Are unable to or unwilling to undergo multiple venipunctures because of poor tolerability or lack of easy access.
Clinical diagnosis of cognitive impairment or dementia.
Known sensitivity to nutritional supplements.
History of being seen or had intervention/care in Functional Medicine or following Functional Medicine principles.
Currently participating in a supervised diet program.
Use of any investigational drug within 30 days prior to randomization or within 5 half-lives of the investigational agent, whichever is longer.

Study is for people with:

Breast Cancer

Estimated Enrollment:

20

Study ID:

NCT05028101

Recruitment Status:

Recruiting

Sponsor:

Case Comprehensive Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Cleveland Clinic
Cleveland Ohio, 44195, United States More Info
Rebecca Knackstedt, MD PhD
Contact
216-387-0287
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

20

Study ID:

NCT05028101

Recruitment Status:

Recruiting

Sponsor:


Case Comprehensive Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.